Why It Matters
China’s maternity and baby market is undergoing a fundamental shift — from volume to value. Even as the birth rate declines (8.56 million births in 2025, down from 12.4 million in 2019), spending per child is rising, driven by premiumization and parents’ increasing willingness to pay for quality, safety, and clinical efficacy. For foreign brands with premium positioning and category expertise, this transition creates concentrated opportunities in five specific segments.
Market Context
China’s baby product market reached approximately RMB 390 billion (~$54 billion) in 2025, according to China Briefing estimates. The growth trajectory is not linear across categories. The volume story — selling more units — is fading as the birth rate contracts. But the value story — selling higher-priced, higher-margin products to more discerning parents — is accelerating. Foreign brands that succeed in this market do so by targeting specific segments where trust, clinical credibility, and premium quality outweigh domestic price competition.
The Five Segments
1. Infant Formula: The Anchor Category
China’s infant milk formula market was valued at roughly RMB 129 billion (~$18 billion) in 2025 — the single largest market globally by revenue — and is projected to grow at approximately 8% annually through 2030. Growth is driven not by volume (births are declining) but by premiumization. Parents are trading up to formulas with human milk oligosaccharides (HMOs), MFGM, and probiotics. Foreign brands with clinically differentiated products, imported positioning, and cross-border e-commerce testing channels have the strongest entry path.
2. Diapers and Baby Personal Care: Premium Niches
The baby diaper market was estimated at around $8.9 billion in 2024 and is forecast to approach $13.6 billion by the early 2030s. International incumbents (P&G’s Pampers, Kimberly-Clark’s Huggies) compete with domestic challengers, but the fastest growth is in specialty niches: sensitive-skin products, eco-friendly materials, and clean-label toiletries where trust and quality outweigh price.
3. Maternal and Infant Nutrition: Fastest-Growing
Prenatal and postnatal maternal supplements, along with infant nutrition, are the fastest-growing parts of the market. Chinese mothers are increasingly informed about nutrition science and seek clinically framed products. The most effective go-to-market channels are content commerce (Xiaohongshu/Little Red Book) and mother-and-baby specialty store chains, where physician endorsements and mom-community advocacy drive purchase decisions.
4. Postpartum and Childcare Services: Premium Service Model
China has a distinctive premium postpartum confinement industry — “yuesao” (monthly matron) caregivers and dedicated “yuezi” (confinement) centers that charge RMB 50,000-300,000 ($7,000-41,000) for a 28-day stay. This is a low-penetration, high-premium market. For foreign entrants, the best model is management partnerships and brand licensing rather than direct operation. Government-supported childcare (“tuoyu”) for under-threes is also expanding rapidly as a policy priority.
5. Assisted Reproduction (ART): Fast-Growing Frontier
Rising infertility — now affecting an estimated 15-18% of Chinese couples — is driving demand for assisted reproductive technology. China’s ART market was valued at roughly $8 billion in 2025, with annual growth of 12-15%. Foreign companies with differentiated ART products, diagnostic tools, or clinical protocols have a clear entry point, though regulatory approval pathways (NMPA registration for medical devices, clinical trial requirements for pharmaceuticals) require 2-4 years of upfront planning.
The e-commerce channel structure for baby products in China differs sharply from Western markets. In the US and EU, Amazon commands roughly 40% of online baby product sales. In China, the channel mix is fragmented across Tmall (roughly 35% share), JD.com (25%), Douyin/Douyin Live (15%), Xiaohongshu (8%), and a long tail of mom-and-baby specialty applets on WeChat. Each channel requires a different content and pricing strategy: Douyin favors short-video product demonstrations, Xiaohongshu requires authentic mom-testimonial content, and Tmall demands polished brand storytelling with clinical endorsements. Foreign brands typically test demand through cross-border e-commerce (CBEC) on Tmall Global or JD Worldwide before committing to local entity setup and physical retail distribution.
Entry Approach for Foreign Brands
Based on segment analysis and recent market performance, the recommended entry models differ by segment:
- Infant formula and nutrition: Cross-border e-commerce (CBEC) testing → Tmall Global/JD Worldwide listing → eventual local entity for physical retail distribution
- Baby care and diapers: Direct CBEC listing for premium SKUs, local joint venture for mass-market distribution
- Services (postpartum, childcare): Brand licensing and management partnership with established local operators
- ART products: NMPA registration pathway, targeting tier-1 hospital partnerships for clinical validation
One Data Point
The number to remember: $54 billion — the estimated size of China’s maternity and baby market in 2025, with the fastest-growing segments (nutrition and ART) expanding at 12-15% annually while births continue to decline. The market is not shrinking — it is reconfiguring toward fewer, richer customers.
— China Gateway 360 —
Remote China market entry support, built around execution.
On broader consumer-market shifts, see China Inbound Tourism Rebound: The USD 300 Billion Opportunity.
For the EV sector where premium foreign brands compete, read China Rolls Back NEV Tax Breaks as EV Sales Hit 58% Market Penetration.
